Novartis Kao
This article was originally published in The Tan Sheet
Executive Summary
Joint venture created by Novartis Consumer Health, Kao Corp. to market OTCs in Japan dissolved, firms announce March 26. Partnership was created in July 2000 with a portfolio expected to include new products developed for Japanese market, international brands, Rx drugs suitable for OTC switch (1"The Tan Sheet" Aug. 7, 2000, In Brief). Parent companies realized "initial expectations were not likely to be met within the timeframe they had originally agreed upon," Novartis says, adding it remains interested in increasing its OTC presence in Japan, particularly through switches...